ClinicalTrials.gg
Status unknownNCT01942707Updated Mar 29, 2018Results posted

Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery

An interventional study of abdominoplasty with Scarpa's Fascia and Abdominoplasty without Scarpa´s Facia in Seroma, sponsored by Federal University of São Paulo. Status unknown at 1 site in Brazil. Open to female participants aged 24 Years to 55 Years. Per ClinicalTrials.gov, last updated 2018-03-29.

Sponsored by Federal University of São Paulo · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
24 Years to 55 Years
Sex
Female
01

Study summary

46 female postbariatric patients will be submitted to anchor-line abdominoplasty with drains insertion. Patients will be randomized to two groups. One group will have the Fascia Scarpa removed and in the other the Fascia Scarpa will be preserved. The drains will be removed when the volume is less than 30 ml in 24 hours. The primary outcome will be the volume of total drainage obtained in the drains of the abdominal region. Secondary outcomes will be the length of time the drains remain and the presence of seroma assessed by ultrasound on the twentieth postoperative day.

Read the detailed description

Morbid obesity has been increasing in Brazil and the world and bariatric surgery is the most effective and long-lasting treatment. This leads to large weight losses leading to large body deformities due to excess skin and subcutaneous tissue. The most common post-bariatric plastic surgery is post-bariatric abdominoplasty which main complication is seroma. PURPOSE: To evaluate the effect of Scarpa fascia preservation in seroma reduction. METHODS: A total of 46 patients were randomly assigned to two groups. One group will have the Fascia Scarpa removed and in the other the Fascia Scarpa will be preserved. The drains will be removed when the volume is less than 30 ml in 24 hours. The primary outcome will be the volume of total drainage obtained in the drains of the abdominal region. Secondary outcomes will be the length of time the drains remain and the presence of seroma assessed by ultrasound on the twentieth postoperative day.

02

Conditions studied

  • Seroma

Browse trials for

Keywords

  • Abdominoplasty,Seroma,Bariatric surgery
03

In context

Seroma

101 studies on the registry are indexed under Seroma; 22 are open to participants now.

This study's enrollment of 46 is below the median of 100 across 92 interventional studies indexed under Seroma.

Browse Seroma studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 439 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • between 22 and 30 Kg/m2
  • Female post-bariatric patient

Exclusion criteria

Exclusion Criteria:

  • neoplasms
  • Diabetes
  • lymphatic system diseases
  • abdominal scars except C section and bariatric surgery scars
  • mental disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
46 participants (actual)

Study arms

  • Active comparator
    Abdominoplasty without Scarpa´s Facia

    Anchor-line abdominoplasty where the Scarpa's Fascia will be removed.

    Procedure: Abdominoplasty without Scarpa´s Facia

  • Experimental
    abdominoplasty with Scarpa's Fascia

    Anchor-line abdominoplasty where the Scarpa's Fascia will be preserved.

    Procedure: abdominoplasty with Scarpa's Fascia

Interventions

  • Procedureabdominoplasty with Scarpa's Fascia

    During surgical detachment of the abdominal flap the Scarpa´s fascia is preserved.

  • ProcedureAbdominoplasty without Scarpa´s Facia

    During surgical detachment of the abdominal flap the Scarpa´s fascia is removed.

06

What researchers measure

Primary outcomes

  1. Total Volume of Drainage in ml.

    We will measure the total volume of drainage, in ml, obtained by the drains in the abdominal region. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours. Total volume of drainage will be calculated as the sum of the volumes obtained daily.

    Time frame: number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days

Secondary outcomes

  1. Number of Days Required for Drain Withdrawal.

    Number of days required for drain withdrawal. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours.

    Time frame: Number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days

  2. Volume of Seroma Assessed by Ultrasound of the Abdominal Wall.

    An ultrasound of the abdominal wall will be realized to check the volume of any residual seroma.

    Time frame: Done after 20 days of surgery

07

Results

Posted Aug 3, 2017

Participant flow

The recruitment began in october 2014 until april 2015 at Hospital Santo Amaro (private hospital), in Guarujá city, Brazil.

Participant flow — Overall Study
MilestoneAnchor-line Abdominoplasty Without Scarpa's FasciaAnchor-line Abdominoplasty With Scarpa's Fascia
Started2323
Completed2323
Not completed00

Outcome measures

PrimaryTotal Volume of Drainage in ml.

We will measure the total volume of drainage, in ml, obtained by the drains in the abdominal region. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours. Total volume of drainage will be calculated as the sum of the volumes obtained daily.

Time frame:
number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days
Reported as:
Mean · ml
Total Volume of Drainage in ml.
mlWithout Scarpa's FasciaWith Scarpa's Fascia
Total Volume of Drainage in ml.428.9 ± 222.6249.1 ± 98.2
Statistical analysis
  • Without Scarpa's Fascia vs With Scarpa's Fascia · Wilcoxon (Mann-Whitney) · p = 0.003 · Mean difference (final values): 179
SecondaryNumber of Days Required for Drain Withdrawal.

Number of days required for drain withdrawal. The measure of drainage will be done at the same time (8:00 am) and by the same nurse everyday in all patients until the drain is withdrawn. The drain will be withdrawn when the drained volume is less than 30 ml in 24 hours.

Time frame:
Number of days required for drain withdrawal (drained volume less than 30 ml in 24 hours) and no later than 10 days
Reported as:
Mean · days
Number of Days Required for Drain Withdrawal.
daysWithout Scarpa's FasciaWith Scarpa's Fascia
Number of Days Required for Drain Withdrawal.5.4 ± 1.94.2 ± 1.2
Statistical analysis
  • Without Scarpa's Fascia vs With Scarpa's Fascia · t-test, 2 sided · p = 0.012 · Mean difference (final values): 1.2
SecondaryVolume of Seroma Assessed by Ultrasound of the Abdominal Wall.

An ultrasound of the abdominal wall will be realized to check the volume of any residual seroma.

Time frame:
Done after 20 days of surgery
Reported as:
Mean · ml
Volume of Seroma Assessed by Ultrasound of the Abdominal Wall.
mlWithout Scarpa's FasciaWith Scarpa's Fascia
Volume of Seroma Assessed by Ultrasound of the Abdominal Wall.21.6 ± 40.716.8 ± 25
Statistical analysis
  • Without Scarpa's Fascia vs With Scarpa's Fascia · Wilcoxon (Mann-Whitney) · p = 0.809 · Mean difference (final values): 4.8

Adverse events

Collected over 60 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Anchor-line Abdominoplasty Without Scarpa's Fascia0/23 (0%)0/23 (0%)0/23 (0%)
Anchor-line Abdominoplasty With Scarpa's Fascia0/23 (0%)0/23 (0%)0/23 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)No Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
Mean37.086 ± 8.0638.1304 ± 8.0537.6087 ± 8.074
Sex: Female, Male
Sex: Female, Male(Participants)No Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
Female232346
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)No Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race232346
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)No Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
Brazil232346
BMI
BMI(Kg/m2)No Keeping Scarpa's FasciaKeeping Scarpa's FasciaTotal
Mean26.4 ± 328.2 ± 1.927.3 ± 2.6
08

Study locations

1 site
  • Federal University of São Paulo
    São Paulo, SP 04024002, Brazil
09

References and documents

Publications

  • Andrades P, Prado A. Composition of postabdominoplasty seroma. Aesthetic Plast Surg. 2007 Sep-Oct;31(5):514-8. doi: 10.1007/s00266-007-0078-3. Epub 2007 Jul 20. PubMed 17659406 ↗
  • Andrades P, Prado A, Danilla S, Guerra C, Benitez S, Sepulveda S, Sciarraffia C, De Carolis V. Progressive tension sutures in the prevention of postabdominoplasty seroma: a prospective, randomized, double-blind clinical trial. Plast Reconstr Surg. 2007 Sep 15;120(4):935-946. doi: 10.1097/01.prs.0000253445.76991.de. PubMed 17805122 ↗
  • Baroudi R, Ferreira CA. Seroma: how to avoid it and how to treat it. Aesthet Surg J. 1998 Nov-Dec;18(6):439-41. doi: 10.1016/s1090-820x(98)70073-1. PubMed 19328174 ↗
  • Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724. Erratum In: JAMA. 2005 Apr 13;293(14):1728. PubMed 15479938 ↗
  • Bussolaro RA, Garcia EB, Zanella MT, Ferreira LM. Impaired abdominal skin sensory function in morbid obesity and after bariatric surgery. Obes Surg. 2012 Mar;22(3):353-9. doi: 10.1007/s11695-011-0485-z. PubMed 21805192 ↗
  • Bercial ME, Sabino Neto M, Calil JA, Rossetto LA, Ferreira LM. Suction drains, quilting sutures, and fibrin sealant in the prevention of seroma formation in abdominoplasty: which is the best strategy? Aesthetic Plast Surg. 2012 Apr;36(2):370-3. doi: 10.1007/s00266-011-9807-8. Epub 2011 Aug 20. PubMed 21858593 ↗
  • Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003641. doi: 10.1002/14651858.CD003641.pub2. PubMed 16235331 ↗
  • Costa LF, Landecker A, Manta AM. Optimizing body contour in massive weight loss patients: the modified vertical abdominoplasty. Plast Reconstr Surg. 2004 Dec;114(7):1917-23; discussion 1924-6. doi: 10.1097/01.prs.0000142997.63346.95. PubMed 15577368 ↗
  • Dellon AL. Fleur-de-lis abdominoplasty. Aesthetic Plast Surg. 1985;9(1):27-32. doi: 10.1007/BF01570680. PubMed 3158172 ↗
  • Di Martino M, Nahas FX, Barbosa MVJ, Montecinos Ayaviri NA, Kimura AK, Barella SM, Novo NF, Ferreira LM. Seroma in lipoabdominoplasty and abdominoplasty: a comparative study using ultrasound. Plast Reconstr Surg. 2010 Nov;126(5):1742-1751. doi: 10.1097/PRS.0b013e3181efa6c5. PubMed 20639797 ↗
  • Costa-Ferreira A, Rebelo M, Vasconez LO, Amarante J. Scarpa fascia preservation during abdominoplasty: a prospective study. Plast Reconstr Surg. 2010 Apr;125(4):1232-1239. doi: 10.1097/PRS.0b013e3181d0ac59. PubMed 20072084 ↗
  • Farah AB, Nahas FX, Ferreira LM, Mendes Jde A, Juliano Y. Sensibility of the abdomen after abdominoplasty. Plast Reconstr Surg. 2004 Aug;114(2):577-82; discussion 583. doi: 10.1097/01.prs.0000128356.93462.7b. PubMed 15277836 ↗
  • Fraccalvieri M, Datta G, Bogetti P, Verna G, Pedrale R, Bocchiotti MA, Boriani F, Obbialero FD, Kefalas N, Bruschi S. Abdominoplasty after weight loss in morbidly obese patients: a 4-year clinical experience. Obes Surg. 2007 Oct;17(10):1319-24. doi: 10.1007/s11695-007-9235-7. PubMed 18000727 ↗
  • Garcia-Garcia ML, Martin-Lorenzo JG, Campillo-Soto A, Torralba-Martinez JA, Liron-Ruiz R, Miguel-Perello J, Mengual-Ballester M, Aguayo-Albasini JL. [Complications and level of satisfaction after dermolipectomy and abdominoplasty post-bariatric surgery]. Cir Esp. 2014 Apr;92(4):254-60. doi: 10.1016/j.ciresp.2013.04.024. Epub 2013 Dec 18. Spanish. PubMed 24360407 ↗
  • Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934. PubMed 24149519 ↗
  • James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004 Jul-Aug;22(4):276-80. doi: 10.1016/j.clindermatol.2004.01.010. PubMed 15475226 ↗
  • Koller M, Hintringer T. Scarpa fascia or rectus fascia in abdominoplasty flap elevation: a prospective clinical trial. Aesthetic Plast Surg. 2012 Apr;36(2):241-3. doi: 10.1007/s00266-011-9795-8. Epub 2011 Aug 19. PubMed 21853405 ↗
  • Le Louarn C. Partial subfascial abdominoplasty. Aesthetic Plast Surg. 1996 Mar-Apr;20(2):123-7. doi: 10.1007/BF02275530. PubMed 8661592 ↗
  • Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005 Apr 5;142(7):547-59. doi: 10.7326/0003-4819-142-7-200504050-00013. PubMed 15809466 ↗
  • Mohammad JA, Warnke PH, Stavraky W. Ultrasound in the diagnosis and management of fluid collection complications following abdominoplasty. Ann Plast Surg. 1998 Nov;41(5):498-502. doi: 10.1097/00000637-199811000-00008. PubMed 9827952 ↗
  • Montano-Pedroso JC, Garcia EB, Omonte IR, Rocha MG, Ferreira LM. Hematological variables and iron status in abdominoplasty after bariatric surgery. Obes Surg. 2013 Jan;23(1):7-16. doi: 10.1007/s11695-012-0720-2. PubMed 22820956 ↗
  • Nahas FX, Ferreira LM, Ghelfond C. Does quilting suture prevent seroma in abdominoplasty? Plast Reconstr Surg. 2007 Mar;119(3):1060-4; discussion 1065-6. doi: 10.1097/01.prs.0000242493.11655.68. PubMed 17312514 ↗
  • Nahas FX, di Martino M, Ferreira LM. Fibrin glue as a substitute for quilting suture in abdominoplasty. Plast Reconstr Surg. 2012 Jan;129(1):212e-213e. doi: 10.1097/PRS.0b013e3182365d65. No abstract available. PubMed 22186572 ↗
  • Neaman KC, Hansen JE. Analysis of complications from abdominoplasty: a review of 206 cases at a university hospital. Ann Plast Surg. 2007 Mar;58(3):292-8. doi: 10.1097/01.sap.0000239806.43438.54. PubMed 17471135 ↗
  • Persichetti P, Simone P, Scuderi N. Anchor-line abdominoplasty: a comprehensive approach to abdominal wall reconstruction and body contouring. Plast Reconstr Surg. 2005 Jul;116(1):289-94. doi: 10.1097/01.prs.0000170049.94288.d2. PubMed 15988280 ↗
  • Pitanguy I. Evaluation of body contouring surgery today: a 30-year perspective. Plast Reconstr Surg. 2000 Apr;105(4):1499-514; discussion 1515-6. PubMed 10744246 ↗
  • Rossetto LA, Garcia EB, Abla LF, Neto MS, Ferreira LM. Quilting suture in the donor site of the transverse rectus abdominis musculocutaneous flap in breast reconstruction. Ann Plast Surg. 2009 Mar;62(3):240-3. doi: 10.1097/SAP.0b013e318180c8e2. PubMed 19240517 ↗
  • Saldanha OR, Federico R, Daher PF, Malheiros AA, Carneiro PRG, Azevedo SFD, Saldanha Filho OR, Saldanha CB. Lipoabdominoplasty. Plast Reconstr Surg. 2009 Sep;124(3):934-942. doi: 10.1097/PRS.0b013e3181b037e3. PubMed 19730314 ↗
  • Stewart KJ, Stewart DA, Coghlan B, Harrison DH, Jones BM, Waterhouse N. Complications of 278 consecutive abdominoplasties. J Plast Reconstr Aesthet Surg. 2006;59(11):1152-5. doi: 10.1016/j.bjps.2005.12.060. Epub 2006 Jul 5. PubMed 17046623 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2013, a primary completion of Apr 2018 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2013
First posted
Sep 16, 2013
Start
Mar 2013
Primary completionEst.
Apr 2018
CompletionEst.
Dec 2018
Results first posted
Aug 3, 2017
Last update
Mar 29, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01942707
Responsible party
Heraldo Carlos Borges (M D - Professor, Federal University of São Paulo) — Principal investigator
First posted
Sep 16, 2013
Start date
Mar 2013
Primary completion
Apr 2018 (estimated)
Completion
Dec 2018 (estimated)
Results posted
Aug 3, 2017
Last update
Mar 29, 2018

Study contacts

Lydia M Ferreira, MD, Phd
study chair · Federal University of São Paulo
Juan C Montano-Pedroso, PhD
study chair · Federal University of São Paulo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion